Month: May 2022

An emerging treatment option for men on active surveillance

Active surveillance for prostate cancer has its tradeoffs. Available to men with low- and intermediate-risk prostate cancer, the process entails monitoring a man’s tumor with periodic biopsies and prostate-specific antigen (PSA) tests, and treating only when — or if — the disease shows signs of progression. Active surveillance allows men to avoid (at least for …

An emerging treatment option for men on active surveillance Read More »

Colon cancer screening decisions: What’s the best option and when?

Colorectal cancer (CRC) is the second leading cause of cancer deaths in the United States, and rates are rising, particularly in adults ages 20 to 49. Unfortunately, approximately 30% of eligible people in the US still have not been screened for CRC. Colon cancer may be prevented with screening tests that look for cancer or …

Colon cancer screening decisions: What’s the best option and when? Read More »